相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
Irina Rusinova et al.
NUCLEIC ACIDS RESEARCH (2013)
The updated biology of hypoxia-inducible factor
Samantha N. Greer et al.
EMBO JOURNAL (2012)
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Daniel J. Gough et al.
IMMUNITY (2012)
Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies
Tim Eisen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
A semi-parametric generalization of the Cox proportional hazards regression model: Inference and applications
Karthik Devarajan et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2011)
Targeted-Therapy in Advanced Renal Cell Carcinoma
M. T. Pirrotta et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The Epidemiology of Renal Cell Carcinoma
Borje Ljungberg et al.
EUROPEAN UROLOGY (2011)
The emerging role of nuclear factor kappa B in renal cell carcinoma
Christudas Morais et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Distinct Roles for the NF-κB RelA Subunit during Antiviral Innate Immune Responses
Suresh H. Basagoudanavar et al.
JOURNAL OF VIROLOGY (2011)
NF-κB Protects Cells from Gamma Interferon-Induced RIP1-Dependent Necroptosis
Roshan J. Thapa et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
Evaluation and Management of the Renal Mass
David Y. T. Chen et al.
MEDICAL CLINICS OF NORTH AMERICA (2011)
Defining Emerging Roles for NF-κB in Antivirus Responses: Revisiting the Interferon-β Enhanceosome Paradigm
Siddharth Balachandran et al.
PLOS PATHOGENS (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex
Alan D. Brooks et al.
MOLECULAR CANCER RESEARCH (2010)
The genetic basis of kidney cancer: a metabolic disease
W. Marston Linehan et al.
NATURE REVIEWS UROLOGY (2010)
Targeted therapies for renal cell carcinoma: understanding their impact on survival
Sumanta Kumar Pal et al.
TARGETED ONCOLOGY (2010)
High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
Maria V. Yusenko et al.
BMC CANCER (2009)
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
Rameen Beroukhim et al.
CANCER RESEARCH (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Role of the VHL (von Hippel-Lindau) gene in renal cancer:: a multifunctional tumour suppressor
Michelle J. Nyhan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody
Anil Shanker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
Ingrid Cifola et al.
MOLECULAR CANCER (2008)
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-κB agonist Card9 by CK2
Haifeng Yang et al.
MOLECULAR CELL (2007)
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma
Michelle L. Gumz et al.
CLINICAL CANCER RESEARCH (2007)
Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7
Siddharth Balachandran et al.
JOURNAL OF IMMUNOLOGY (2007)
Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib
Jiabin An et al.
MOLECULAR CANCER THERAPEUTICS (2007)
RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis
Fangxin Hong et al.
BIOINFORMATICS (2006)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
IRF-7 is the master regulator of type-I interferon-dependent immune responses
K Honda et al.
NATURE (2005)
VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-κB-dependent mechanism
JB An et al.
ONCOGENE (2005)
Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
JB An et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations
R Stoyanova et al.
CANCER BIOLOGY & THERAPY (2004)
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma
RI Sufan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data
ME Lenburg et al.
BMC CANCER (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma
M Oya et al.
CARCINOGENESIS (2003)
Stimulation of IRF-7 gene expression by tumor necrosis factor α -: Requirement for NFκB transcription factor and gene accessibility
RQ Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The interferon-α/β system in antiviral responses:: a multimodal machinery of gene regulation by the IRF family of transcription factors
T Taniguchi et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
A weak signal for strong responses:: Interferon-α/β revisited
T Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
